Future events will be posted here

Learning Objectives

Introduction:  Biomedical Reductionism: The Good, the Bad, and the Debatable

Stuart Kelter, PsyD


Participants will be able to:

  • Define the meaning/mechanism duality as applied to physical ailments,such as hypertension and pain syndromes.
  • Explain the meaning/mechanism duality as applied to at least two psychiatric disorders.
  • Name two clinical situations in which biomedical reductionism is helpful and two in which it is unhelpful.



It’s All in Your Mind. Or Is It? Placebo and Nocebo Effects

Stuart Kelter, PsyD


Participants will be able to:

  • Explain the difference between apparent and real placebo/nocebo effects.
  • Evaluate the relative contribution of the placebo component to medication efficacy for antidepressants.
  • Define three possible ways of harnessing the placebo effect in the act of prescribing medications.
  • Identify two ethical dilemmas raised by knowingly prescribing placebos and medications whose efficacy derives .
  • mostly from placebo effects.
  • Identify two ethical dilemmas raised by disclosing possible side-effects.



A Case Study Using an Integrative Approach to Patient Care

Arthur Berkson, MD


Participants will be able to:

  • Name the main components of an integrative medicine perspective to a complicated patient.
  • Identify at least one clinical criteria for the clinical use of low dose naltrexone.
  • Identify at least two supplements, including alpha-lipoic acid, and their clinical use.
  • Name the basic components of the anti-inflammatory diet.
  • Identify at least two basic concepts pertaining to the inividualizing of mind-body medicine modalities.



Three Innovative Treatments for Schizophrenia: Implications for Understanding Serious Mental Illness 

and Its Treatment

Al Galves, PhD 


Participants will be able to:

  • List three innovative treatments for schizophrenia that invoke the self-healing powers of patients.
  • Identify the distinguishing characteristics of the three innovative treatments for schizophrenia.
  • List at least four implications of the three innovative treatments for schizophrenia for treatment of other mental disorders.



Support Groups and Psychotherapy With Voice Hearers: A Clinical Perspective

Kevin Hennelly, MA, MS, JD, LPCC


Participants will be able to:

  • Name the three major theoretical models that explain voice hearing.
  • List three major impediments to establishing and maintaining a therapeutic relationship with voice hearers.
  • Name three clinical interventions that help voice hearers to maintain control of their thoughts and actions.
  • Identify three specific strategies to prevent voice hearing from interfering with treating co-occurring disorders such as PTSD, depression, and anxiety.
  • Name four core principles for facilitating support groups for voice hearers.